Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men
Hao Li, Yangchang Zhang, Li Chen, Jiuhong Yuan, Feng Qin, Xianding Wang, Yang Xiong · 2026
Read Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men by Hao Li, Yangchang Zhang, Li Chen, Jiuhong Yuan, Feng Qin, Xianding Wang, Yang Xiong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13261327.txt.
Description
Hao Li and colleagues present a 2026 prospective cohort study seeking blood protein signatures that predict benign prostatic hyperplasia. This non-cancerous prostate enlargement is common in older men and causes urinary symptoms. No protein markers existed for predicting who will develop it.
The team followed 20,996 BPH-free men from the UK Biobank and measured 2,920 plasma proteins. Over a median follow-up of 13.38 years, 2,405 men developed the condition. Cox regression linked 92 proteins to risk. A machine-learning model prioritized three: TSPAN1 and KLK3 raised risk, while EDA2R was protective. Together they predicted onset with an AUC of 0.71. Enrichment analysis pointed to immune-inflammatory pathways and tissue remodeling. Genetic analysis suggested TSPAN1 and KLK3 are causally involved, marking them as possible targets for risk assessment and therapy.
Catalog record
| CREATOR | Hao Li, Yangchang Zhang, Li Chen, Jiuhong Yuan, Feng Qin, Xianding Wang, Yang Xiong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36528 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |